Pharmacology and clinical evaluation of degarelix
Abstract：Degarelix is a GnRH receptor antagonist that is indicated for the treatment of advanced prostate cancer. To provide references for clinical medication, literature for degarelix was searched, and its pharmacology, pharmacodynamics, and clinical evaluation were reviewed.
Keywords：degarelixprostate cancerclinical pharmacologyclinical evaluation
Publication Date：2010-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)